FutureWise analysis estimates the biomarker market at $59.1 billion in 2023, with projections to reach $148.64 billion by 2031, growing at a CAGR of 12.20%. This growth is supported by the adoption of precision medicine, increased use of biomarkers in diagnostics and drug development, and advancements in genomics, proteomics, and digital health technologies.
Uploaded 6 months ago
Direct links
Image link
Image URL
Full image (linked)
Website (HTML)
Forums (BBCode)
Share image
Image information:
FutureWise analysis estimates the biomarker market at $59.1 billion in 2023, with projections to reach $148.64 billion by 2031, growing at a CAGR of 12.20%. This growth is supported by the adoption of precision medicine, increased use of biomarkers in diagnostics and drug development, and advancements in genomics, proteomics, and digital health technologies.